Compare · AMRS vs LYB
AMRS vs LYB
Side-by-side comparison of Amyris Inc. (AMRS) and LyondellBasell Industries NV (LYB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMRS and LYB operate in Major Chemicals (Industrials), so they compete in similar markets.
- LYB is the larger of the two at $20.54B, about 16.4x AMRS ($1.25B).
- LYB has hit the wire 19 times in the past 4 weeks while AMRS has been quiet.
- LYB has more recent analyst coverage (25 ratings vs 13 for AMRS).
- Company
- Amyris Inc.
- LyondellBasell Industries NV
- Price
- $0.06-10.57%
- $65.78+3.43%
- Market cap
- $1.25B
- $20.54B
- 1M return
- -
- -10.55%
- 1Y return
- -
- +8.54%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2010
- News (4w)
- 0
- 19
- Recent ratings
- 13
- 25
Amyris Inc.
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
LyondellBasell Industries NV
LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and PolyolefinsÂAmericas; Olefins and PolyolefinsÂEurope, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology. It produces and markets olefins and co-products; polyolefins; polyethylene products, which consist of high density polyethylene, low density polyethylene, and linear low density polyethylene; and polypropylene (PP) products, such as PP homopolymers and copolymers. The company also produces and sells propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomers, acetyls, ethylene glycols, and ethylene oxides and derivatives. In addition, it produces and markets compounds and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors, and powders; and advanced polymers. Further, the company refines crude oil and other crude oils of varied types and sources into gasoline, diesel, and jet fuel; develops and licenses chemical and polyolefin process technologies; and manufactures and sells polyolefin catalysts. LyondellBasell Industries N.V. was founded in 1955 and is headquartered in Houston, Texas.
Latest AMRS
- AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
- Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
- SEC Form S-8 POS filed by Amyris Inc.
- SEC Form S-8 POS filed by Amyris Inc.
- SEC Form S-8 POS filed by Amyris Inc.
- SEC Form S-8 POS filed by Amyris Inc.
- SEC Form POS AM filed by Amyris Inc.
- SEC Form POS AM filed by Amyris Inc.
- SEC Form S-8 POS filed by Amyris Inc.
- SEC Form S-8 POS filed by Amyris Inc.
Latest LYB
- SEC Form 4 filed by EVP & Chief Innovation Officer Seward James Malcolm
- SEC Form 4 filed by EVP, Sustainability & Corp Aff Campbell Tracey D
- LyondellBasell Industries NV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form SD filed by LyondellBasell Industries NV
- LyondellBasell upgraded by Wells Fargo with a new price target
- SEC Form S-8 filed by LyondellBasell Industries NV
- Director Griffin Rita E was granted 2,321 units of Class A Ordinary Shares and covered exercise/tax liability with 639 units of Class A Ordinary Shares, increasing direct ownership by 30% to 7,354 units (SEC Form 4) to cover taxes
- Director Manifold Albert Jude was granted 2,321 units of Class A Ordinary Shares and covered exercise/tax liability with 689 units of Class A Ordinary Shares, increasing direct ownership by 12% to 14,905 units (SEC Form 4) (for tax liability)
- Director Karlin Bridget E was granted 2,321 units of Class A Ordinary Shares and covered exercise/tax liability with 521 units of Class A Ordinary Shares, increasing direct ownership by 37% to 6,705 units (SEC Form 4) to satisfy withholding tax
- Director Kamsky Virginia A was granted 2,321 units of Class A Ordinary Shares and covered exercise/tax liability with 593 units of Class A Ordinary Shares, increasing direct ownership by 21% to 9,822 units (SEC Form 4) to satisfy withholding tax